{"id":"W2965327853","doi":"10.1177/2047487319864671","title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","year":2019,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"National Institutes of Health; Esperion Therapeutics; Ionis Pharmaceuticals; Mylan; National Institute for Health and Care Research; Medicines Company; Amarin Corporation; Sanofi; Kowa Company; Regeneron Pharmaceuticals; American Heart Association; Pfizer; Amgen; Abbott Diagnostics; European Atherosclerosis Society; Eli Lilly and Company","keywords":"Ezetimibe; Medicine; Internal medicine; Placebo; Statin; Clinical endpoint; Fixed-dose combination; Familial hypercholesterolemia; Combination therapy; Cholesterol; Gastroenterology; Endocrinology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339896,0.0002246692,0.0008280777,0.0002177971,0.00004440437,0.00001947068,0.00009808387,0.0000532238,0.00002015091],"category_scores_gemma":[0.00004228103,0.0001432998,0.0001255771,0.0002038371,0.000093959,0.0001398561,0.00003245796,0.0005143808,0.00001120536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001130332,"about_ca_system_score_gemma":0.0001214849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003016844,"about_ca_topic_score_gemma":0.000004277371,"domain_scores_codex":[0.9966164,0.002038937,0.0004680829,0.0002812968,0.0003383205,0.0002569465],"domain_scores_gemma":[0.998644,0.00003970826,0.0004334131,0.0002753751,0.0004648624,0.0001426477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008560147,0.0001982319,0.9364104,0.00005722337,0.001172085,0.0006906377,0.0005323829,0.0003757186,0.000628838,0.000007102547,0.0000522733,0.05131494],"study_design_scores_gemma":[0.02993406,0.01014104,0.9582807,0.0002874263,0.000181363,0.0002790097,0.0001161784,0.00001331204,0.0002334077,0.000006441367,0.0003794669,0.0001475625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972023,0.0005842671,0.00067927,0.00008421139,0.00007745457,0.0008317967,0.00001650012,0.00001167145,0.0005125462],"genre_scores_gemma":[0.9983543,0.0005572979,0.0006863649,0.0001496877,0.00008149035,0.00000427072,0.00004722251,0.00004848019,0.00007085441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05116737,"threshold_uncertainty_score":0.5843596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006406354205373587,"score_gpt":0.2084279197838719,"score_spread":0.2020215655784983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}